<DOC>
	<DOC>NCT00751413</DOC>
	<brief_summary>To evaluate the safety, tolerability and plasma levels of single oral doses of MK0633 in pediatric asthma patients ages 6 to less than 12 years.</brief_summary>
	<brief_title>Plasma Levels of MK0633 in Children Ages 6-12 (0633-023)</brief_title>
	<detailed_description />
	<criteria>Patient has mild to moderate asthma Patient is able to swallow pills Patient is able to have have blood draws Patient has required a visit to the hospital or emergency room due to an asthmatic event in the last 3 months Patient has an upper respiratory tract infection (URI) Patient has a history of stroke Patient consumes more than 4 caffeinated beverages per day</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>